Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

  • The following terms were not found in PubMed: Cannabidiol%3A, schizophrenia%3F.
1.

Cannabinoids, cannabis, and cannabis-based medicine for pain management: a protocol for an overview of systematic reviews and a systematic review of randomised controlled trials.

Fisher E, Eccleston C, Degenhardt L, Finn DP, Finnerup NB, Gilron I, Haroutounian S, Krane E, Rice ASC, Rowbotham M, Wallace M, Moore RA.

Pain Rep. 2019 Apr 30;4(3):e741. doi: 10.1097/PR9.0000000000000741. eCollection 2019 May-Jun.

2.

Is (poly-) substance use associated with impaired inhibitory control? A mega-analysis controlling for confounders.

Liu Y, van den Wildenberg WPM, de Graaf Y, Ames SL, Baldacchino A, Bø R, Cadaveira F, Campanella S, Christiansen P, Claus ED, Colzato LS, Filbey FM, Foxe JJ, Garavan H, Hendershot CS, Hester R, Jester JM, Karoly HC, Kräplin A, Kreusch F, Landrø NI, Littel M, Loeber S, London ED, López-Caneda E, Lubman DI, Luijten M, Marczinski CA, Metrik J, Montgomery C, Papachristou H, Mi Park S, Paz AL, Petit G, Prisciandaro JJ, Quednow BB, Ray LA, Roberts CA, Roberts GMP, de Ruiter MB, Rupp CI, Steele VR, Sun D, Takagi M, Tapert SF, van Holst RJ, Verdejo-Garcia A, Vonmoos M, Wojnar M, Yao Y, Yücel M, Zack M, Zucker RA, Huizenga HM, Wiers RW.

Neurosci Biobehav Rev. 2019 Oct;105:288-304. doi: 10.1016/j.neubiorev.2019.07.006. Epub 2019 Jul 15. Review.

3.

Maternal and paternal cannabis use during pregnancy and the risk of psychotic-like experiences in the offspring.

Bolhuis K, Kushner SA, Yalniz S, Hillegers MHJ, Jaddoe VWV, Tiemeier H, El Marroun H.

Schizophr Res. 2018 Dec;202:322-327. doi: 10.1016/j.schres.2018.06.067. Epub 2018 Jul 6.

PMID:
29983267
4.

Δ9-Tetrahydrocannabinol at Retrieval Drives False Recollection of Neutral and Emotional Memories.

Doss MK, Weafer J, Gallo DA, de Wit H.

Biol Psychiatry. 2018 Nov 15;84(10):743-750. doi: 10.1016/j.biopsych.2018.04.020. Epub 2018 May 9.

PMID:
29884456
5.

Same-Sex Friendship, School Gender Composition, and Substance Use: A Social Network Study of 50 European Schools.

Grard A, Kunst A, Kuipers M, Richter M, Rimpela A, Federico B, Lorant V.

Subst Use Misuse. 2018 May 12;53(6):998-1007. doi: 10.1080/10826084.2017.1392976. Epub 2017 Nov 30.

PMID:
29190174
6.

Topical Medical Cannabis: A New Treatment for Wound Pain-Three Cases of Pyoderma Gangrenosum.

Maida V, Corban J.

J Pain Symptom Manage. 2017 Nov;54(5):732-736. doi: 10.1016/j.jpainsymman.2017.06.005. Epub 2017 Aug 14.

PMID:
28818631
7.

A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.

Gray KM, Sonne SC, McClure EA, Ghitza UE, Matthews AG, McRae-Clark AL, Carroll KM, Potter JS, Wiest K, Mooney LJ, Hasson A, Walsh SL, Lofwall MR, Babalonis S, Lindblad RW, Sparenborg S, Wahle A, King JS, Baker NL, Tomko RL, Haynes LF, Vandrey RG, Levin FR.

Drug Alcohol Depend. 2017 Aug 1;177:249-257. doi: 10.1016/j.drugalcdep.2017.04.020. Epub 2017 Jun 10.

8.

Marijuana Use and Self-reported Quality of Eyesight.

Akano OF.

Optom Vis Sci. 2017 May;94(5):630-633. doi: 10.1097/OPX.0000000000001069.

PMID:
28422803
9.

Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.

Rosenberg EC, Patra PH, Whalley BJ.

Epilepsy Behav. 2017 May;70(Pt B):319-327. doi: 10.1016/j.yebeh.2016.11.006. Epub 2017 Feb 9. Review.

10.

Comparison of Parent, Peer, Psychiatric, and Cannabis Use Influences Across Stages of Offspring Alcohol Involvement: Evidence from the COGA Prospective Study.

Bucholz KK, McCutcheon VV, Agrawal A, Dick DM, Hesselbrock VM, Kramer JR, Kuperman S, Nurnberger JI Jr, Salvatore JE, Schuckit MA, Bierut LJ, Foroud TM, Chan G, Hesselbrock M, Meyers JL, Edenberg HJ, Porjesz B.

Alcohol Clin Exp Res. 2017 Feb;41(2):359-368. doi: 10.1111/acer.13293. Epub 2017 Jan 10.

11.

Role of cannabis in digestive disorders.

Goyal H, Singla U, Gupta U, May E.

Eur J Gastroenterol Hepatol. 2017 Feb;29(2):135-143. doi: 10.1097/MEG.0000000000000779. Review.

PMID:
27792038
12.

Solar retinopathy following cannabis consumption.

Chawla R, Mittal K, Venkatesh P, Sharma YR.

Clin Exp Optom. 2017 Jan;100(1):92-93. doi: 10.1111/cxo.12421. Epub 2016 Aug 16. No abstract available.

13.

Marijuana Legalization: Impact on Physicians and Public Health.

Wilkinson ST, Yarnell S, Radhakrishnan R, Ball SA, D'Souza DC.

Annu Rev Med. 2016;67:453-66. doi: 10.1146/annurev-med-050214-013454. Epub 2015 Oct 19. Review.

14.

Cannabis: a self-medication drug for weight management? The never ending story.

Bersani FS, Santacroce R, Coviello M, Imperatori C, Francesconi M, Vicinanza R, Minichino A, Corazza O.

Drug Test Anal. 2016 Feb;8(2):177-9. doi: 10.1002/dta.1891. Epub 2015 Oct 12.

PMID:
26456495
15.

Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts.

Schwantes-An TH, Zhang J, Chen LS, Hartz SM, Culverhouse RC, Chen X, Coon H, Frank J, Kamens HM, Konte B, Kovanen L, Latvala A, Legrand LN, Maher BS, Melroy WE, Nelson EC, Reid MW, Robinson JD, Shen PH, Yang BZ, Andrews JA, Aveyard P, Beltcheva O, Brown SA, Cannon DS, Cichon S, Corley RP, Dahmen N, Degenhardt L, Foroud T, Gaebel W, Giegling I, Glatt SJ, Grucza RA, Hardin J, Hartmann AM, Heath AC, Herms S, Hodgkinson CA, Hoffmann P, Hops H, Huizinga D, Ising M, Johnson EO, Johnstone E, Kaneva RP, Kendler KS, Kiefer F, Kranzler HR, Krauter KS, Levran O, Lucae S, Lynskey MT, Maier W, Mann K, Martin NG, Mattheisen M, Montgomery GW, Müller-Myhsok B, Murphy MF, Neale MC, Nikolov MA, Nishita D, Nöthen MM, Nurnberger J, Partonen T, Pergadia ML, Reynolds M, Ridinger M, Rose RJ, Rouvinen-Lagerström N, Scherbaum N, Schmäl C, Soyka M, Stallings MC, Steffens M, Treutlein J, Tsuang M, Wall TL, Wodarz N, Yuferov V, Zill P, Bergen AW, Chen J, Cinciripini PM, Edenberg HJ, Ehringer MA, Ferrell RE, Gelernter J, Goldman D, Hewitt JK, Hopfer CJ, Iacono WG, Kaprio J, Kreek MJ, Kremensky IM, Madden PA, McGue M, Munafò MR, Philibert RA, Rietschel M, Roy A, Rujescu D, Saarikoski ST, Swan GE, Todorov AA, Vanyukov MM, Weiss RB, Bierut LJ, Saccone NL.

Behav Genet. 2016 Mar;46(2):151-69. doi: 10.1007/s10519-015-9737-3. Epub 2015 Sep 21.

16.

Early Cannabis Use, Polygenic Risk Score for Schizophrenia and Brain Maturation in Adolescence.

French L, Gray C, Leonard G, Perron M, Pike GB, Richer L, Séguin JR, Veillette S, Evans CJ, Artiges E, Banaschewski T, Bokde AW, Bromberg U, Bruehl R, Buchel C, Cattrell A, Conrod PJ, Flor H, Frouin V, Gallinat J, Garavan H, Gowland P, Heinz A, Lemaitre H, Martinot JL, Nees F, Orfanos DP, Pangelinan MM, Poustka L, Rietschel M, Smolka MN, Walter H, Whelan R, Timpson NJ, Schumann G, Smith GD, Pausova Z, Paus T.

JAMA Psychiatry. 2015 Oct;72(10):1002-11. doi: 10.1001/jamapsychiatry.2015.1131.

17.

Medical use of cannabis. Cannabidiol: a new light for schizophrenia?

Deiana S.

Drug Test Anal. 2013 Jan;5(1):46-51. doi: 10.1002/dta.1425. Epub 2012 Oct 25.

PMID:
23109356
18.

[Cannabis and urine samples].

Westin AA.

Tidsskr Nor Laegeforen. 2011 Mar 18;131(6):577-80. doi: 10.4045/tidsskr.09.1111. Review. Norwegian.

19.

Moral regulation and the presumption of guilt in Health Canada's medical cannabis policy and practice.

Lucas P.

Int J Drug Policy. 2009 Jul;20(4):296-303. doi: 10.1016/j.drugpo.2008.09.007. Epub 2009 Jan 4.

PMID:
19124233

Supplemental Content

Loading ...
Support Center